Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protein preload and vildagliptin in men with type 2 diabetes
ACTRN12612001005842Phase 4Not yet recruiting
- Sponsor
- Professor Michael Horowitz
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vildagliptin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Professor Michael Horowitz. Primary endpoint: Blood glucose levels. Planned start Oct 2012; status: not yet recruiting.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12612001005842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001005842.